Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,784 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

NCT03012100

Conditions
Bilateral Breast Carcinoma, Breast Diseases, Breast Inflammatory Carcinoma, +18 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View Trial Details
Active, not recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, not recruiting

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

NCT01273610

Conditions
Behavior, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • South Pasadena Cancer Center Pasadena, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

NCT05646862

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Cancer Blood and Specialty Clinic Los Alamitos, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 145 locations
View Trial Details

Related conditions